Publication:
A fatal case of Ecthyma Gangrenosum in a critically ill and immunocompromised patient

dc.contributor.authorTomanovic, Marija (58092757700)
dc.contributor.authorReljic, Vesna (55895308600)
dc.contributor.authorPeric, Jelena (55894863200)
dc.contributor.authorZivanovic, Dubravka (24170307900)
dc.date.accessioned2025-06-12T12:06:11Z
dc.date.available2025-06-12T12:06:11Z
dc.date.issued2023
dc.description.abstractIntroduction: This brief picture-oriented case report focuses on typical skin lesions in a patient who developed Ecthyma gangrenosum and pseudomonal sepsis after extensive immunosuppressive therapy for Pemphigus vulgaris. Case presentation: The patient was immunosuppressed with high doses of glucocorticoids and azathioprine; the follow-up after the treatment was not carried out well due to the pandemic conditions and because the patient herself got a Covid infection, which resulted in the development of pseudomonal sepsis and Ecthyma gangrenosum. The outcome was fatal despite extensive broad-spectrum antibiotic therapy, plasmapheresis, and intravenous immunoglobulins. Conclusions: Infections with Pseudomonas aeruginosa have become a real concern in hospital-acquired infections, especially in critically ill and immunocompromised patients, because of multi-drug resistance in the first place. Copyright © 2023 Tomanovic et al.
dc.identifier.urihttps://doi.org/10.3855/jidc.18040
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85179608003&doi=10.3855%2fjidc.18040&partnerID=40&md5=996196cf16543d0f3e34bfb292522eff
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/2489
dc.subjectEcthyma gangrenosum
dc.subjectimmunocompromised
dc.subjectPemphigus vulgaris
dc.subjectPseudomonas aeruginosa
dc.subjectsepsis
dc.titleA fatal case of Ecthyma Gangrenosum in a critically ill and immunocompromised patient
dspace.entity.typePublication

Files